---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-22-000047"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2022-04-13T23:59:59+00:00"
generated_at: "2026-06-26T07:36:44.311113+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AtriCure launches EnCompass Clamp for cardiac ablation in US

## Summary
- FDA 510(k) clearance for cardiac tissue ablation; features parallel closure, uniform pressure, custom RF power.
- Magnetic guide enables easier placement with minimal dissection; designed for closed-atrium cardiac surgery.
- CEO states clamp provides simpler, faster approach; surgeon cites single-pass efficiency for posterior wall lesions.

## SEC filing metadata
- accession: 0001323885-22-000047
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2022-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388522000047/0001323885-22-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388522000047/atrc-20220412.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-22-000047
- JSON: https://secwatch.observer/filing/0001323885-22-000047.json
- Plain text: https://secwatch.observer/filing/0001323885-22-000047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.